Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001641172-25-016887
Filing Date
2025-06-27
Accepted
2025-06-27 16:11:01
Documents
16
Effectiveness Date
2025-06-27

Document Format Files

Seq Description Document Type Size
1 S-8 forms-8.htm S-8 53597
2 EX-5.1 ex5-1.htm EX-5.1 17319
3 EX-23.1 ex23-1.htm EX-23.1 3304
4 EX-23.2 ex23-2.htm EX-23.2 2133
5 EX-FILING FEES ex-107.htm   iXBRL EX-FILING FEES 19420
6 GRAPHIC ex5-1_001.jpg GRAPHIC 3656
  Complete submission text file 0001641172-25-016887.txt   222044

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT ex-107_htm.xml XML 5730
Mailing Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040
Business Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-288386 | Film No.: 251086402
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)